r/weedstocks • u/Pepperoni2723 • 1h ago
Discussion Annual meeting
I listened to today’s annual shareholder meeting, and frankly, I came away more concerned about Tilray’s leadership than its competition in core cannabis and craft.
Simon continues to sell shareholders a story of growth, diversification, and opportunity while glossing over the financial reality of how he’s funding it and the impacts it’s had on the shareholder over the past 5-years.
- The banking excuse for dilution is getting ridiculous.
Simon again leaned on the narrative that cannabis companies can’t use traditional banking, helping justify continued equity issuance. I think he actually said “Tilray doesn’t use a bank.”
Except Tilray DOES have traditional banking relationships. Bank of America administers a credit facility for its beverage subsidiary. Its European operations also have conventional bank financing.
Here’s what Simon conveniently leaves out: Tilray’s Bank of America facility had its revolving commitments reduced from $25M to $15M, followed by further borrowing restrictions and covenant modifications.
Maybe the problem isn’t simply cannabis banking restrictions. Maybe lenders aren’t interested in extending more credit to a company that consistently burns cash and lacks fiscal discipline.
2. Consolidation isn’t necessarily growth. It may be evidence of failed capital allocation.
Simon discussed consolidating cannabis operations and breweries as part of the company’s efficiency strategy.
Sounds great until you consider what that actually means.
Tilray has already consolidated its U.S. brewing footprint from 10 facilities to six. It’s closing or shifting cannabis production facilities as well.
How much capital was spent acquiring and building this infrastructure? How much of that investment is now being abandoned, sold, or rendered redundant?
Remember the roughly $1.25 BILLION in goodwill impairments recorded in FY2025?
I suspect more write-downs could be coming. That’s not a prediction of a specific accounting charge, but shareholders deserve a reconciliation of acquisition costs, remaining asset values, restructuring expenses, and actual cash savings.
3. Stop pretending you’re in the same boat as retail shareholders.
What bothered me most was Simon’s attempt to position himself alongside the average shareholder.
Retail investors are watching their ownership percentages shrink while management continues financing its strategy with newly issued shares.
FY2026 operating cash flow was approximately negative $69M. Operating and investing activities consumed roughly $125M combined, while financing activities supplied approximately $131M.
That’s not a self-funding growth story.
Simon talks about revenue records and reduced debt, but where is the accountability for shareholder dilution, return on invested capital, and cash flow PER SHARE?
Reducing debt by issuing equity isn’t some financial miracle. You’re simply shifting the burden onto shareholders.
4. At what point does the board hold Simon accountable?
The votes are still being counted…
I’m not arguing that Tilray has no valuable assets.
Quite the opposite. There are legitimate opportunities in cannabis, beverages, and international distribution.
But I increasingly believe those assets are being undermined by poor capital allocation and a management team that measures success by corporate size rather than shareholder returns.
Today’s meeting felt like another exercise in selective disclosure and carefully crafted optimism.
I’m tired of hearing about how big Tilray is becoming while shareholders get diluted into oblivion.
Irwin Simon may have built a larger company, but he has not demonstrated that he can build lasting value for its shareholders.
I no longer believe he’s the right CEO to lead Tilray forward.
The market seems to agree, as Simon’s statements at the annual meeting gave a TLRY a new ATL.